Just days after announcing a comprehensive rebrand as it shifts its focus to international markets, Organigram Global has acquired Hamilton-based
Canadian cannabis giant Organigram has officially rebranded as it pivots its strategy towards international operations. The newly dubbed Organigram Global
London Stock Exchange-listed (LSE) UK medical cannabis operator Kanabo has published its broad financial results for 2024, revealing growing revenue and falling losses.
British American Tobacco Tobacco giant British American Tobacco (BAT) has announced the launch of a second investment fund as
Argent BioPharma Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June
Jazz Pharmaceuticals The pharmaceutical giant announced last week that its flagship cannabinoid treatment, Epidyolex, failed to pass its Phase
Organigram has reported a 25% year-on-year increase in revenues over its third quarter as sales in its home market rebounded.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to
Canadian cannabis giant Organigram has announced a new three-year supply deal in the UK as it continues to focus efforts
As earnings season gets into full swing, Canada’s Organigram has become the latest major cannabis operator to publish its financial
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
